Variation in preoperative antithrombotic strategy, severe bleeding and use of blood products in coronary artery bypass grafting. Results from the multicenter E-CABG registry
Background:
No data exists on inter-institutional differences in terms of adherence to international guidelines regarding the discontinuation of antithrombotics and rates of severe bleeding in coronary artery bypass grafting (CABG).
Methods and Results: